These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 33492764

  • 1. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S.
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [Abstract] [Full Text] [Related]

  • 2. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
    Yun SO, Kim J, Rhu J, Choi GS, Joh JW.
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 4. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH, Kim DG, Kang M, Koh HH, Choi MC, Min EK, Lee JG, Kim MS, Joo DJ.
    Int J Surg; 2023 Nov 01; 109(11):3459-3466. PubMed ID: 37565633
    [Abstract] [Full Text] [Related]

  • 5. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr 01; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 6. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.
    Transplantation; 2024 Mar 01; 108(3):713-723. PubMed ID: 37635282
    [Abstract] [Full Text] [Related]

  • 7. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C, Liu H, Zhang X, Ganoza A, Crane A, Powers C, Gunabushanam V, Behari J, Molinari M.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38837956
    [Abstract] [Full Text] [Related]

  • 8. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 08; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 9. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 08; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 10. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep 08; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 11. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 12. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May 01; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

  • 13. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoğlu OM, D'Alessandro AM, Acarlı KS, Kalayoğlu M, Fernandez LA.
    Turk J Med Sci; 2021 Apr 30; 51(2):610-622. PubMed ID: 33037873
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC, Fung JY, Pang HH, Leung CK, Li HF, Sin SL, Ma KW, She BW, Dai JW, Chan AC, Cheung TT, Lo CM.
    Hepatology; 2021 Jun 30; 73(6):2441-2454. PubMed ID: 33006772
    [Abstract] [Full Text] [Related]

  • 15. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.
    Liver Transpl; 2012 Feb 30; 18(2):160-5. PubMed ID: 22006378
    [Abstract] [Full Text] [Related]

  • 16. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, Renner EL, Selzner M, Ghanekar A, Levy G, Grant DR.
    Transpl Int; 2013 Aug 30; 26(8):780-7. PubMed ID: 23746118
    [Abstract] [Full Text] [Related]

  • 17. Superior Long-Term Outcomes of Adult Living Donor Liver Transplantation: A Cumulative Single-Center Cohort Study With 20 Years of Follow-Up.
    Goto T, Ivanics T, Cattral MS, Reichman T, Ghanekar A, Sapisochin G, McGilvray ID, Sayed B, Lilly L, Bhat M, Selzner M, Selzner N.
    Liver Transpl; 2022 May 30; 28(5):834-842. PubMed ID: 34870890
    [Abstract] [Full Text] [Related]

  • 18. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA.
    JAMA Surg; 2022 Oct 01; 157(10):926-932. PubMed ID: 35921119
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group.
    Liver Transpl; 2007 Jan 01; 13(1):122-9. PubMed ID: 17192908
    [Abstract] [Full Text] [Related]

  • 20. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
    Ziogas IA, Alexopoulos SP, Matsuoka LK, Geevarghese SK, Gorden LD, Karp SJ, Perkins JD, Montenovo MI.
    Clin Transplant; 2020 Oct 01; 34(10):e14031. PubMed ID: 33427333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.